Industry Deals

We've scoured the airwaves and assembled a list of the latest financial transactions in technology and communications.

Pear Therapeutics Completes $64M Series C Financing

BOSTON–(BUSINESS WIRE)–Pear Therapeutics, Inc., the leader in prescription digital therapeutics, today announced that it has successfully closed a $64 million Series C financing led by Temasek, and joined by other existing investors including Novartis, 5AM Ventures, Arboretum Ventures, Jazz Venture Partners, The Bridge Builders Collaborative, and Singapore-based EDBI.